 |
|
|
|
| Selected Reading |
 Abd H, Johansson T, Golovliov I, et al. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol 2003 Jan;69(1):600-6 [Full text]
Akalin H, Helvaci S, Gedikoglu S. Re-emergence of tularemia in Turkey. Int J Infect Dis 2009 Sep;13(5):547-51 [Abstract]
Allue M, Ruiz Sopena C, Gallardo MT, et al. Tularemia outbreak in Castilla y Leon, Spain, 2007: an update. Eurosurveillance 2008 Aug 7;13(32):pii=18948 [Full text]
Anderson RV, Crane DD, Bosio CM. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine 2010 Sep 14;28(40):6562-72 [Abstract]
Avashia SB, Petersen JM, Lindley CM, et al. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg Infect Dis 2004 Mar;10(3):483-6 [Full text]
Bakshi CS, Malik M, Mahawar M, et al. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis ScuS4 strain. Vaccine 2008 Sep 26;26(41):5276-88 [Abstract]
Baron SD, Singh R, Metzger DW. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun 2007 May;75(5):2152-62 [Abstract]
Beckstrom-Sternberg SM, Auerbach RK, Godbole S, et al. Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS ONE 2007 Sep 26;2(9):e947 [Full text]
Berrada ZL, Goethert HK, Telford SR III. Raccoons and skunks as sentinels for enzootic tularemia. Emerg Infect Dis 2006 Jun;12(6):1019-21 [Full text]
Broms JE, Lavander M, Meyer L, et al. IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS. Infect Immun 2011 Sep;79(9):3683-96 [Abstract]
Brotcke A, Weiss DS, Kim CK, et al. Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun 2006 Dec;74(12):6642-55 [Abstract]
Byington CL, Bender JM, Ampofo K, et al. Tularemia with vesciular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis 2008 Jul 1;47(1):e4-6 [Full text]
Carlson PE Jr, Carroll JA, O'dee DM, et al. Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Microb Pathog 2007 May-Jun;42(5-6):204-14 [Abstract]
CDC. Laboratory Information>Biosafety>Vaccines [Table]
CDC. Outbreak of tularemia among commercially distributed prairie dogs, 2002. MMWR 2002;51(31):688,699 [Full text]
CDC. Tularemia -- Missouri, 2000 - 2007. MMWR 2009 Jul 17;58(27):744-8 [Full text]
CDC. Tularemia associated with a hamster bite: Colorado 2004. MMWR 2005 Jan 7;53(51 & 52):1202-3 [Full text]
CDC. Tularemia transmitted by insect bites: Wyoming, 2001-2003. MMWR 2005 Feb 25;54(7):170-3 [Full text]
CDC. Tularemia: United States, 1990-2000. MMWR 2002;51(09):182-4 [Full text]
Cepheid. Cepheid ships field-ready DNA test kits jointly developed with USAMRIID for four bio-threat agents. Jan 7, 2002 [Press release]
Charity JC, Costante-Hamm MM, Balon EL, et al. Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis. PLoS Pathog 2007 Jun;4(6):e84 [Full text]
Chaudhuri RR, Ren CP, Desmond L, et al. Genome sequencing shows that European isolates of Francisella tularensis subspecies tularensis are almost identical to US laboratory strain Schu S4. PLoS One 2007 Apr;2(4):e352 [Full text]
Clemens DL, Lee BY, Horwitz MA. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 2005 Sep;73(9):5892-902. [Full text]
Clemens DL, Lee TY, Horwitz MA. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun 2004 Jun;72(6):3204-17 [Abstract]
Conlan JW, Chen W, Shen H, et al. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb Pathog 2003 May;34(5):239-48 [Abstract]
Conlan JW. Francisella tularensis: a red-blooded pathogen. (Commentary) J Infect Dis 2011 Jul 1;204(1):6-8 [Abstract]
Craven RR, Hall JD, Fuller JR, et al. Francisella tularensis invasion of lung epithelial cells. Infect Immun 2008 Jul;76(7):2833-42 [Abstract]
Cunha BA. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Rev 2002 Aug 8(8):489-503 [Abstract]
Decors A, Lesage C, Jourdain E, et al. Outbreak of tularaemia in brown hares (Lepus europaeus) in France, January to March 2011. Euro Surveill 2011 Jul 14;16(28):pii=19913 [Full text]
Dembek ZF, Buckman RL, Fowler SK, et al. Missed sentinel case of naturally occurring pneumonic tularemia outbreak: lessons for detection of bioterrorism. J Am Board Fam Pract 2003 Jul-Aug;16(4):339-42 [Full text]
Dempsey MP, Dobson M, Zhang C, et al. Genomic deletion marking an emerging subclone of Francisella tularensis subsp holarctica in France and the Iberian peninsula. Appl Environ Microbiol 2007 Nov;73(22):7465-70 [Abstract]
Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285(21):2763-73 [Full text]
Dyer MD, Neff C, Dufford M, et al. The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis. PLoS ONE 2010 Aug 9;5(8):e12089 [Full text]
Egan JR, Hall IM, Leach S. Modeling inhalational tularemia: deliberate release and public health response. Biosecur Bioterror 2011 (published online Nov 1) [Abstract]
El Sahly HM, Atmar RL, Patel SM, et al. Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine 2009 Aug 6;27(36):4905-11 [Abstract]
Eliasson H, Lindback J, Nuorti JP. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis 2002(Sep);8(9):956-60 [Full text]
Eliasson H, Olcen P, Sjostedt A, et al. Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test. Clin Vaccine Immunol 2008 Aug;15(8):1238-43 [Abstract]
Ellis J, Oyston PCF, Green M, et al. Tularemia. Clin Microbiol Rev 2002 Oct;15(4):631-46 [Abstract]
Emanuel PA, Bell R, Dang JL, et al. Detection of Francisella tularensis within infected mouse tissues by using a hand-held PCR thermocycler. J Clin Microbiol 2003;41(2):689-93 [Abstract]
Evans ME, Friedlander AM. Tularemia. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Chap 24. Washington, DC: Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center [Full text]
Farlow J, Wagner DM, Dukerich M, et al. Francisella tularensis in the United States. Emerg Infect Dis 2005 Dec;11(12):1835-41 [Full text]
Feldman KA, Stiles-Enos D, Julian K, et al. Tularemia on Martha's Vineyard: seroprevalence and occupational risk. Emerg Infect Dis 2003 Mar;9(3):350-4 [Full text]
Forestal CA, Malik M, Catlett SV, et al. Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis 2007 Jul 1;196(1):134-7 [Abstract]
Gentry M, Taormina J, Pyles RB, et al. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection. Infect Immun 2007 Aug;75(8):3969-78 [Abstract]
Gil H, Platz GJ, Forestal CA, et al. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci 2006 Aug 22;103(34):12897-902 [Abstract]
Goethert HK, Shani I, Telford SR III. Genotypic diversity of Francisella tularensis infecting Dermacentor variabilis ticks on Martha's Vineyard, Massachusetts. J Clin Microbiol 2004 Nov;42(11):4968-73 [Abstract]
Goethert HK, Telford SR III. Nonrandom distribution of vector ticks (Dermacentor variabilis) infected by Francisella tularensis. PLoS Pathog 2009 Feb 27;5(2):e1000319 [Full text]
Gyuranecz M, Rigo K, Dan A, et al. Investigation of the ecology of Francisella tularensis during an inter-epizootic period. Vector Borne Zoonotic Dis 2011 Aug;11(8):1031-5 [Abstract]
Hall JD, Craven RR, Fuller JR, et al. Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation. Infect Immun 2007 Feb;75(2):1034-9 [Abstract]
Hassoun A, Spera R, Dunkel J. Tularemia and once-daily gentamicin. Antimicrob Agents Chemother 2006 Feb;50(2):824. [Full text]
Hauri AM, Hofstetter I, Seibold E, et al. Investigating an airborne tularemia outbreak, Germany. (Letter) Emerg Infect Dis 2010 Feb;16(2):238-43 [Full text]
Hazlett KRO, Caldon SD, McArthur DG, et al. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect Immun 2008 Oct;76(10):4479-88 [Abstract]
Hepburn MJ, Purcell BK, Lawler JV, et al. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia. Clin Infect Dis 2006 Sep 15;43(6):711-6 [Abstract]
Hickey AJ, Hazlett KRO, Kirimanjeswara GS, et al. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 2011 Sep 16;29(40):6941-7 [Abstract]
Hornick R. Tularemia revisited. N Engl J Med 2001;345(22):1637-9 [Full text]
Horzempa J, Carlson PE Jr, O'Dee DM, et al. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis. BMC Microbiol 2008 Oct 8;8:172 [Abstract]
Horzempa J, O'Dee DM, Stolz DB, et al. Invasion of erythrocytes by Francisella tularensis. J Infect Dis 2011 Jul 1;204(1):51-9 [Abstract]
Hotta A, Uda A, Fujita O, et al. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis. Clin Vaccine Immunol 2007 Jan;14(1):81-4 [Abstract]
Huntley JF, Conley PG, Hagman KE, et al. Characterization of Francisella tularensis outer membrane proteins. J Bacteriol 2007 Jan;189(2):561-7 [Abstract]
Huntley JF, Conley PG, Rasko DA, et al. Native outer membrance proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect Immun 2008 Aug;76(8):3664-71 [Abstract]
Ireland R, Olivares-Zavaleta N, Warawa JM, et al. Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. PloS Pathog 2010 May 27;6(5):e1000921 [Full text]
Isherwood KE, Titball RW, Davies DH, et al. Vaccination strategies for Francisella tularensis. Adv Drug Deliv Rev 2005 Jun 17;57(9):1403-14 [Full text]
Jia Q, Lee BY, Bowen R, et al. A Francisella tularensis live vaccine strain mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet potent protective immunity in mice against F. tularensis challenge. Infect Immun 2010 Oct;78(10):4341-55 [Abstract]
Jia Q, Lee BY, Clemens DL, et al. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis iglC induces protection in mice against aerosolized Type A F tularensis. Vaccine 2009 Feb 18;27(8):1216-29 [Abstract]
Kantardjiev T, Ivanov I, Velinov T, et al. Tularemia outbreak, Bulgaria, 1997-2005. Emerg Infect Dis 2006;12(4):678-80 [Full text]
Kantardjiev TV, Padeshki PI, Ivanov IN. Diagnostic approaches for oculoglandular tularemia-advantages of PCR. Br J Ophthalmol 2007 Sep;91(9):1206-8 [Abstract]
Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997;3(2):83-94 [Full text]
Kaysser P, Seibold E, Matz-Rensing K, et al. Re-emergence of tularemia in Germany: presence of Francisella tularensis in different rodent species in endemic areas. BMC Infect Dis 2008 Nov 17;8:157 [Abstract]
Kim DY, Reilly TJ, Schommer SK, et al. Rabbit tularemia and hepatic coccidiosis in wild rabbit. (Letter) Emerg Infect Dis 2010 Dec;16(12):2016-7 [Full text]
Kirimanjeswara GS, Golden JM, Bakshi CS, et al. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol 2007 Jul 1;179(1):532-9 [Abstract]
Kugeler KJ, Mead PS, Janusz AM, et al. Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis 2009 Apr 1;48(7):863-70 [Abstract]
Kugeler KJ, Mead PS, McGowan KL, et al. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol 2008 Jul;46(7):2428-31 [Abstract]
KuoLee R, Harris G, Conlan JW, et al. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F tularensis. Vaccine 2007;May 10;25(19):3781-91 [Abstract]
KuoLee R, Zhao X, Austin J, et al. Mouse model of oral infection with virulent type A Francisella tularensis. Infect Immun 2007 Apr;75(4):1651-60 [Abstract]
Larssen KW, Afset JE, Heier BT, et al. Outbreak of tularemia in central Norway, January to March 2011. Euro Surveill 2011 Mar 31;16(13):pii=19828 [Full text]
Larsson P, Svensson K, Karlsson L, et al. Canonical insertion-deletion markers for rapid DNA-based typing of Francisella tularensis. Emerg Infect Dis 2007 Nov;13(11):1725-32 [Full text]
Lavine CL, Clinton SR, Angelova-Fischer I, et al. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Eur J Immunol 2007 Nov;37(11):3007-20 [Abstract]
Lembo A, Pelletier M, Iyer R, et al. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J Immunol 2008 Jun 1;180(11):7574-81 [Abstract]
Lindemann SR, McLendon MK, Apicella MA, et al. An in vitro model system used to study adherence and invasion of Francisella tularenisis live vaccine strain in nonphagocytic cells. Infect Immun 2007 Jun;75(6):3178-82 [Abstract]
Lopes de Carvalho I, Escudero R, Garcia-Amil C, et al. Francisella tularensis, Portugal. Emerg Infect Dis 2007 Apr;13(4):666-7 [Full text]
Mahy S, Chavanet P, Piroth L, et al. Emergence of tularemia in France: paradigm of the Burgundy region. Int J Infect Dis 2011 (published online Oct 5) [Abstract]
Mann BJ, Ark NM. Rationally designed tularemia vaccines. Expert Rev Vaccines 2009 Jul;8(7):877-85 [Abstract]
Mara-Koosham G, Hutt JA, Lyons CR, et al. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun 2011 Apr;79(4):1770-8 [Abstract]
Mara-Koosham G, Hutt JA, Lyons CR, et al. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis. Infect Immun 2011 Apr;79(4):1770-8 [Abstract]
Martin C, Gallardo MT, Mateos L, et al. Outbreak of tularemia in Castilla y Leon, Spain. Eurosurveillance Weekly 2007 Nov 8;12(11):pii=3302 [Full text]
Matz-Rensing K, Floto A, Schrod A, et al. Epizootic of tularemia in an outdoor housed group of cynomolgus monkeys (Macaca fascicularis). Vet Pathol 2007 May;44(3):327-34 [Abstract]
Maurin M, Pelloux I, Brion JP, et al. Human tularemia in France, 2006-2010. Clin Infect Dis 2011 Nov 15;53(10):e133-41 [Abstract]
McCaffrey RL, Allen L-AH. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J Leukoc Biol 2006 Dec;80(6):1224-30 [Abstract]
McMurry JA, Gregory SH, Moise L, et al. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine 2007 Apr;25(16):3179-91 [Abstract]
Meric M, Willke A, Finke EJ, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS 2008 Jan;116(1):66-73 [Abstract]
Mohapatra NP, Balagopal A, Soni S, et al. AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infect Immun 2007 Jan;75(1):390-6 [Abstract]
Mohapatra NP, Soni S, Bell BL, et al. Identification of an orphan response regulator required for the virulence of Francisella spp and transcription of pathogenicity island genes. Infect Immun 2007 Jul;75(7):3305-14 [Abstract]
Molins-Schneekloth CR, Belisle JT, Petersen JM. Genomic markers for differentiation of Francisella tularensis subsp tularensis A.I and A.II strains. Appl Environ Microbiol 2008 Jan;74(1):336-41 [Abstract]
Murphy T, Rolfs A, Hu Y, et al. A full-genomic sequence-verified protein-coding gene collection for Francisella tularensis. PLoS One 2007 Jun;2(6):e577 [Full text]
Nelson M, Lever MS, Savage VL, et al. Establishment of lethal inhalational infection with Francisella tularenis (tularemia) in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2009 Apr;90(2):109-18 [Abstract]
Nigrovic LE, Wingerter SL. Tularemia. Infect Dis Clin North Am 2008 Sep;22(3):489-504 [Abstract]
Niska RW, Burt CW. Training for terrorism-related conditions in hospitals: United States, 2003-04. Adv Data 2006 Dec 11;(380):1-9 [Full text]
O'Brien KK, Higdon NL, Halverson JJ. Recognition and management of bioterrorism infections. Am Fam Physician 2003 May 1;67(9):1927-34 [Full text]
Ojeda SS, Wang ZJ, Mares CA, et al. Rapid dissemination of Francisella tularensis and the effect of route of infection. BMC Microbiol 2008 Dec 9;8:215 [Abstract]
Oyston PCF. Francisella tularensis: unravelling the secrets of an intracellular pathogen. J Med Microbiol 2008 Aug;57(8):921-30 [Full text]
Padeshki PI, Ivanov IN, Popov B, et al. The role of birds in dissemination of Francisella tularensis: first direct molecular evidence for bird-to-human transmission. Epidemiol Infect 2009 Mar;3(138):376-9 [Abstract]
Pammit MA, Raulie EK, Lauriano CM, et al. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun 2006 Apr;74(4):2063-71 [Abstract]
Payne L, Arneborn M, Tegnell A, et al. Endemic tularemia, Sweden, 2003. Emerg Infect Dis 2005 Sep;11(9):1440-2 [Full text]
Pechous RD, McCarthy TR, Mohapatra NP, et al. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 2008 Jun 25;3(6):e2487 [Abstract]
Peruski AH, Johnson LH, Peruski LF. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J Immunol Methods 2002 May 1;263(1-2):35-41 [Abstract]
Petersen JM, Carlson JK, Dietrich G, et al. Multiple Francisella tularensis subspecies and clades, tularemia outbreak, Utah. Emerg Infect Dis 2008 Dec;14(12):1928-30 [Full text]
Petersen JM, Schriefer ME, Carter LG, et al. Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002. Emerg Infect Dis 2004 Mar;10(3):419-25 [Full text]
Peterson JM, Schriefer ME, Gage KL, et al. Methods for enhanced culture recovery of Francisella tularensis. Appl Environ Microbiol 2004 Jun;70(6):3733-5 [Abstract]
Phillips NJ, Schilling B, McLendon MK, et al. Novel modification of lipid A of Francisella tularensis. Infect Immun 2004 Sep;72(9):5340-8 [Abstract]
Prior RG, Klasson L, Larsson P, et al. Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J Appl Microbiol 2001 Oct;91(4):614-20 [Abstract]
Qin A, Scott DW, Thompson JA, et al. Identification of an essential Francisella tularensis subsp tularensis virulence factor. Infect Immun 2009 Jan;77(1):152-61 [Abstract]
Quarry JE, Isherwood KE, Michell SL, et al. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant induces protective immunity to tularemia in mice. Vaccine 2007 Mar 1;25(11):2011-8 [Abstract]
Raynaud C, Meibom KL, Lety MA, et al. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun 2007 Jan;75(1):536-41 [Abstract]
Rohmer L, Brittnacher M, Svensson K, et al. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Infect Immun 2006 Dec;74(12):6895-906 [Abstract]
Russo BC, Horzempa J, O'Dee DM, et al. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Infect Immun 2011 Sep;79(9):3665-76 [Abstract]
Ryden P, Bjork R, Schafer ML, et al. Outbreaks of tularemia in a boreal forest region depend on mosquito prevalence. J Infect Dis 2011 (published online Nov 28) [Abstract]
Savitt AG, Mena-Taboada P, Monsalve G, et al. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection and therapy. Clin Vaccine Immunol 2009 Mar;16(3):414-22 [Abstract]
Schuvert A, Splettstoesser W, Batzing-Feigenbaum J. Tularemia in Berlin -- two independent cases in travelers returning from central Anatolia, Turkey, February 2011. Euro Surveill 2011 May 5;16(18):pii=19860 [Full text]
Sebastian S, Dillon ST, Lynch JG, et al. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 2007 May;75(5):2591-602 [Abstract]
Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol 2003 Jul;41(7):2801-9 [Abstract]
Shapiro DS, Schwartz DR. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 2002 Jun;40(6):2278-81 [Abstract]
Shen H, Harris G, Chen W, et al. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. PLoS ONE 2010 Oct 12;5(10):e13349 [Full text]
Sjodin A, Svensson K, Lindgren M, et al. Whole-genome sequencing reveals distinct mutational patterns in closely related laboratory and naturally propagated Francisella tularensis strains. PLoS ONE 2010 Jul 19;5(7):e11556 [Full text]
Sjostedt A. Virulence determinants and protective antigens of Francisella tularensis. Curr Opin Microbiol 2003 Feb;6(1):66-7 [Abstract]
Staples JE, Kubotga KA, Chalcraft LG, et al. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 2006 Jul;12(7):1113-8 [Full text]
Stupak HD, Scheuller MC, Schindler DN, et al. Tularemia of the head and neck: a possible sign of bioterrorism. Ear Nose Throat J 2003 Apr;82(4):263-5 [Abstract]
Su J, Yang J, Zhao D, et al. Genome-wide identification of Francisella tularensis virulence determinants. Infect Immun 2007 Jun;75(6):3089-101 [Abstract]
Svensson K, Granberg M, Karlsson L, et al. A real-time PCR array for hierarchical identification of Francisella isolates. PLoS One 2009 Dec 21;4(12):e8360 [Abstract]
Thomas R, Johansson A, Neeson B, et al. Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism. J Clin Microbiol 2003 Jan;41(1):50-7 [Abstract]
Titball RW, Johansson A, Forsman M. Will the enigma of Francisella tularensis virulence soon be solved? Trends Microbiol 2003 Mar;11(3):118-23 [Abstract]
Tomaso H, Scholz HC, Neubauer, et al. Real-time PCR using hybridization probes for the rapid and specific identification of Francsisella tularensis subspecies tularensis. Mol Cell Probes 2007 Feb;21(1):12-16 [Abstract]
Twine S, Bystrom M, Chen W, et al. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 2005 Dec;73(12):8345-52 [Full text]
Twine SM, Petit MD, Fulton KM, et al. Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). PLoS ONE 2010 Apr 2;5(4):e10000 [Full text]
Urich SK, Petersen JM. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother 2008 Jun;52(6):2276-8 [Abstract]
Waterer GW, Robertson H. Bioterrorism for the respiratory physician. Respirology 2009 Jan;14(1):5-11 [Abstract]
Weiss DS, Brotcke A, Henry T, et al. In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci 2007 Apr 3;104(14):6037-42 [Abstract]
Wickstrum Jr, Hong KJ, Bokhari S, et al. Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis. Infect Immun 2007 Mar;75(3):1335-42 [Abstract]
Willke A, Meric M, Grunow R, et al. An outbreak of oropharyngeal tularemia linked to natural spring water. J Med Microbiol 2009 Jan;58(1):112-6 [Abstract]
Wu TH, Hutt JA, Garrison KA, et al. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 2005 May 1;73(5):2644-54 [Abstract]
Zarrella TM, Singh A, Bitsaktsis C, et al. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS ONE 2011 Jul 22;6(7):e22335 [Full text]
Zhang F, Liu W, Chu MC, et al. Francisella tularensis in rodents, China. Emerg Infect Dis 2006 Jun;12(6):994-6 [Full text]
|
